Lentiviral vector mediated modification of mesenchymal stem cells & enhanced survival in an in vitro model of ischaemia

Stem Cell Research and Therapy

Volumn 2, Issue 2, 2011, Pages

  McGinley, Lisa ^a   McMahon, Jill ^b   Strappe, Padraig ^c   Barry, Frank ^a   Murphy, Mary ^a   O'Toole, Daniel ^b   O'Brien, Timothy ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c CHARLES STURT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DEOXYGLUCOSE; EXTRACELLULAR SUPEROXIDE DISMUTASE; HEAT SHOCK PROTEIN 70; LENTIVIRUS VECTOR; GREEN FLUORESCENT PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA MODIFICATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE CONSTRUCT; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO GENE TRANSFER; IN VITRO STUDY; ISCHEMIA; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BIOLOGICAL MODEL; CELL HYPOXIA; CYTOLOGY; DRUG EFFECT; GENE VECTOR; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; GLYCOLYSIS; HELA CELL; LENTIVIRINAE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

RATTUS;

ANIMALS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL SURVIVAL; DEOXYGLUCOSE; GENETIC VECTORS; GLYCOLYSIS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; ISCHEMIA; LENTIVIRUS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; RATS; TRANSDUCTION, GENETIC; TRANSFECTION; TRANSGENES;

EID: 79961243719     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt53     Document Type: Article

References (47)

1. Multilineage potential of adult human mesenchymal stem cells. Pittenger MF Mackay AM, Beck SC Jaiswal RK, Douglas R Mosca JD, Moorman MA Simonetti DW, Craig S Marshak DR, Science 1999 284 143 7 10.1126/science.284.5411.143 10102814 (Pubitemid 29282067)
2. Mesenchymal stem cells: clinical applications and biological characterization. Barry FP Murphy JM, Int J Biochem Cell Biol 2004 36 568 84 10.1016/j.biocel.2003.11.001 15010324 (Pubitemid 38324589)
3. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Mahmood A Lu D, Lu M Chopp M, Neurosurgery 2003 53 697 702 discussion 702-3 10.1227/01.NEU.0000079333.61863. AA 12943585
4. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Ryan JM Barry F, Murphy JM Mahon BP, Clin Exp Immunol 2007 149 353 63 10.1111/j.1365-2249.2007.03422.x 17521318 (Pubitemid 47063057)
5. Mesenchymal stem cells avoid allogeneic rejection. Ryan JM Barry FP, Murphy JM Mahon BP, J Inflamm (Lond) 2005 2 8 10.1186/1476-9255-2-8 16045800
6. Human mesenchymal stem cells modulate allogeneic immune cell responses. Aggarwal S Pittenger MF, Blood 2005 105 1815 22 10.1182/blood-2004-04-1559 15494428
7. Immune properties of mesenchymal stem cells. Sotiropoulou PA Papamichail M, Methods Mol Biol 2007 407 225 43 full-text 18453259
8. Stem cell therapy in acute myocardial infarction: a review of clinical trials. George JC, Transl Res 155 10 9 10.1016/j.trsl.2009.06.009 20004357
9. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Mylotte LA Duffy AM Murphy M O'Brien T, Samali A Barry F, Szegezdi E, Stem Cells 2008 26 1325 36 10.1634/stemcells.2007-1072 18308942
10. Enhanced lipoplex-mediated gene expression in mesenchymal stem cells using reiterated nuclear localization sequence peptides. Hoare M Greiser U Schu S Mashayekhi K, Aydogan E Murphy M, Barry F Ritter T, O'Brien T, Gene Med 12 207 18
11. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. McMahon JM Conroy S, Lyons M Greiser U, O'shea C Strappe P, Howard L Murphy M, Barry F O'Brien T, Stem Cells Dev 2006 15 87 96 10.1089/scd.2006.15.87 16522166
12. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Naldini L, Curr Opin Biotechnol 1998 9 5 457 63 10.1016/S0958-1669(98)80029-3 9821272 (Pubitemid 28478965)
13. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Naldini L Blömer U, Gallay P Ory D, Mulligan R Gage FH, Verma IM Trono D, Science 1996 272 263 7 10.1126/science.272.5259.263 8602510 (Pubitemid 26119138)
14. Reevaluation of in vitro differentiation protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal phenotype. Neuhuber B Gallo G, Howard L Kostura L, Mackay A Fischer I, J Neurosci Res 2004 77 192 204 10.1002/jnr.20147 15211586 (Pubitemid 38859404)
15. Effects of plating density and culture time on bone marrow stromal cell characteristics. Neuhuber B Swanger SA Howard L Mackay A, Fischer I, Exp Hematol 2008 36 1176 85 10.1016/j.exphem.2008.03.019 18495329
16. Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Scutt A Bertram P, Calcif Tissue Int 1999 64 69 77 10.1007/s002239900581 9868287 (Pubitemid 29024632)
17. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Mosmann T, J Immunol Methods 1983 65 55 63 10.1016/0022-1759(83)90303-4 6606682 (Pubitemid 14203433)
18. An effective method for adenoviral-mediated delivery of small interfering RNA into mesenchymal stem cells. Forte A Napolitano MA, Cipollaro M Giordano A, Cascino A Galderisi U, J Cell Biochem 2007 100 293 302 10.1002/jcb.21025 16888813
19. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. Lou J Xu F, Merkel K Manske P, J Orthop Res 1999 17 43 50 10.1002/jor.1100170108 10073646 (Pubitemid 29096004)
20. Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy. Kumar S Mahendra G, Nagy TR Ponnazhagan S, Hum Gene Ther 2004 15 1197 206 10.1089/hum.2004.15.1197 15684696 (Pubitemid 40052432)
21. Electric field-induced molecular vibration for noninvasive, high-efficiency DNA transfection. Song L Chau L, Sakamoto Y Nakashima J, Koide M Tuan RS, Mol Ther 2004 9 607 16 10.1016/j.ymthe.2004.01.017 15093191 (Pubitemid 38578811)
22. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Gelse K Von der Mark K Aigner T Park J, Schneider H, Arthritis Rheum 2003 48 430 41 10.1002/art.10759 12571853 (Pubitemid 36278012)
23. Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. Kyriakou CA Yong KL, Benjamin R Pizzey A, Dogan A Singh N, Davidoff AM Nathwani AC, J Gene Med 2006 8 253 64 10.1002/jgm.840 16288493
24. In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector. Worsham DN Schuesler T, Von Kalle C Pan D, Mol Ther 2006 14 514 24 10.1016/j.ymthe.2006.05.014 16893684 (Pubitemid 44296095)
25. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Challita PM Kohn DB, Proc Natl Acad Sci USA 1994 91 2567 71 10.1073/pnas.91.7.2567 8146155 (Pubitemid 24139388)
26. De novo methylation and expression of retroviral genomes during mouse embryogenesis. Jähner D Stuhlmann H Stewart CL Harbers K, Löhler J Simon I, Jaenisch R, Nature 1982 298 623 8 6285203 (Pubitemid 12099716)
27. De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. Stewart CL Stuhlmann H, Jähner D Jaenisch R, Proc Natl Acad Sci USA 1982 79 4098 102 10.1073/pnas.79.13.4098 6955793 (Pubitemid 12035085)
28. Virus infection of murine teratocarcinoma stem cell lines. Teich NM Weiss RA, Martin GR Lowy DR, Cell 1977 12 973 82 10.1016/0092-8674(77)90162-3 202395 (Pubitemid 8236625)
29. Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure. Hino S Fan J Taguwa S Akasaka K, Matsuoka M, Gene Ther 2004 11 819 28 10.1038/sj.gt.3302227 14985785 (Pubitemid 38714585)
30. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Ma Y Ramezani A Lewis R Hawley RG, Thomson JA, Stem Cells 2003 21 111 7 10.1634/stemcells.21-1-111 12529558 (Pubitemid 36120372)
31. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Pfeifer A Ikawa M, Dayn Y Verma IM, Proc Natl Acad Sci USA 2002 99 2140 5 10.1073/pnas.251682798 11854510 (Pubitemid 34169028)
32. Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Ramezani A Hawley TS Hawley RG, Blood 2003 101 4717 24 10.1182/blood-2002-09-2991 12586614
33. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Xia X Zhang Y, Zieth CR Zhang SC, Stem Cells Dev 2007 16 167 76 10.1089/scd. 2006.0057 17348812 (Pubitemid 46362600)
34. Is green fluorescent protein toxic to the living cells? Liu HS Jan MS Chou CK Chen PH, Ke NJ, Biochem Biophys Res Commun 1999 260 712 7 10.1006/bbrc.1999.0954 10403831
35. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Van Damme A Thorrez L, Ma L Vandenburgh H, Eyckmans J Dell'Accio F, De Bari C Luyten F, Lillicrap D Collen D, VandenDriessche T Chuah MK, Stem Cells 2006 24 896 907 10.1634/stemcells.2003-0106 16339997 (Pubitemid 44464723)
36. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Tsuda H Wada T, Ito Y Uchida H, Dehari H Nakamura K, Sasaki K Kobune M, Yamashita T Hamada H, Mol Ther 2003 7 354 65 10.1016/S1525-0016(02)00062-X 12668131 (Pubitemid 36503859)
37. Inhibition of glycolysis in hearts during ischemic perfusion. Neely JR Whitmer JT Rovetto MJ, Recent Adv Stud Cardiac Struct Metab 1975 7 243 8 5756
38. Mechanisms of glycolytic inhibition in ischemic rat hearts. Rovetto MJ Lamberton WF Neely JR, Circ Res 1975 37 742 51 157
39. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Zhu W Chen J Cong X Hu S, Chen X, Stem Cells 2006 24 416 25 10.1634/stemcells.2005-0121 16253984 (Pubitemid 44464811)
40. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Bialik S Cryns VL Drincic A Miyata S, Wollowick AL Srinivasan A, Kitsis RN, Circ Res 1999 85 403 14 10473670
41. H9c2 cardiac myoblasts undergo apoptosis in a model of ischemia consisting of serum deprivation and hypoxia: inhibition by PMA. Bonavita F Stefanelli C, Giordano E Columbaro M, Facchini A Bonafè F, Caldarera CM Guarnieri C, FEBS Lett 2003 536 85 91 10.1016/S0014-5793(03)00029-2 12586343 (Pubitemid 36206411)
42. Rosenzweig A, Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis. Chao W Shen Y Li L, J Biol Chem 2002 277 31639 45 10.1074/jbc.M204104200 12063258 (Pubitemid 34968967)
43. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Grayson WL Zhao F, Bunnell B Ma T, Biochem Biophys Res Commun 2007 358 948 53 10.1016/j.bbrc.2007.05.054 17521616 (Pubitemid 46802482)
44. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. Grayson WL Zhao F Izadpanah R Bunnell B, Ma T, J Cell Physiol 2006 207 331 9 10.1002/jcp.20571 16331674
45. Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Ren H Cao Y Zhao Q Li J, Zhou C Liao L, Jia M Zhao Q, Cai H Han ZC, Yang R Chen G, Zhao RC, Biochem Biophys Res Commun 2006 347 12 21 10.1016/j.bbrc.2006.05.169 16814746 (Pubitemid 44040907)
46. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. Lennon DP Edmison JM Caplan AI, J Cell Physiol 2001 187 345 55 10.1002/jcp.1081 11319758 (Pubitemid 32378359)
47. Bone marrow circulation after osteotomy. Blood flow, pO2, pCO2, and pressure studied in dogs. Kofoed H Sjøntoft E, Siemssen SO Olesen HP, Acta Orthop Scand 1985 56 400 3 10.3109/17453678508994357 3934919 (Pubitemid 16169829)